Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Dec 02, 24
1 min read


iDose® TR represents a revolutionary advancement in the treatment of glaucoma, offering a long-term and efficient method for managing intraocular pressure (IOP). In contrast to traditional eye drops that demand frequent use, iDose® TR is a tiny, implantable device engineered to release a controlled release of medication directly into the eye over an extended period. This innovative approach eliminates the need for frequent dosing, dramatically boosting patient adherence and overall treatment outcomes.

At Eye Center South, we are honored to introduce iDose® TR as part of our comprehensive glaucoma care. The device is placed during a gentle procedure, designed with your ease in mind. Once in place, it ensures a steady flow of treatment, helping to maintain stable IOP levels and protect your vision. Patients who have difficulty managing the demands of frequent eye drop use can find relief from this cutting-edge treatment.



Visit for more info At Eye Center South